One of the most challenging problems facing modern medicine is how to deliver a given drug to a specific target at the exclusion of other regions. For example, a variety of compounds have beneficial e READ MORE http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3761088/
A previous clinical trial demonstrated that four months of treatment with intranasal insulin improves cognition and function for patients with Alzheimer's disease (AD) or mild cognitive impairment (MC READ MORE http://www.ncbi.nlm.nih.gov/pubmed/23507773
Research in animals and humans has associated Alzheimer’s disease (AD) with decreased cerebrospinal fluid levels of insulin in combination with decreased insulin sensitivity (insulin resistance) in th READ MORE http://europepmc.org/articles/PMC3709085
Objective: To examine the effects of intranasal insulin administration on cognition, function, cerebral glucose metabolism, and cerebrospinal fluid biomarkers in adults with amnestic mild cognitive i READ MORE http://archneur.jamanetwork.com/article.aspx...
Alzheimer's and diabetes have much in common, including many risk factors and underlying pathological mechanisms. It stands to reason that treatments which might be helpful for diabetics might also be helpful for Alzheimer's patients.